Articles From: 500.com Limited Provides Additional Information on Temporary Suspension of Sales by Provincial Sports Lottery Administration Centers to CYREN to Present at ROTH Conference


2015/3/2
SHENZHEN, China , March 2, 2015 /PRNewswire/ -- 500.com Limited (NYSE: WBAI) ("500.com" or the "Company"), a leading online sports lottery service provider in China , today made an announcement in furtherance to the Company's announcement on February 25, 2015 with regard to the suspension of sales by certain provincial sports lottery administration centers.
Sign-up for 500.com Limited Provides Additional Information on Temporary Suspension of Sales by Provincial Sports Lottery Administration Centers investment picks
2015/3/2
STAMFORD, Conn., March 2, 2015 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO) , a biopharmaceutical company focused on the discovery, development, and commercialization of targeted cancer therapies, today provided updated 2015 program guidance and unveiled molecular targets for three of its active preclinical programs.
Sign-up for Loxo Oncology Announces 2015 Program Guidance and Reveals Selected Pipeline Programs investment picks
2015/3/2
No Material Changes Relating to Real Estate Ownership, Rental Revenue or Fundamental Business Operations No Changes to the Financial Statements or Operations of the Cole Capital® Sponsored Non-Traded REITs The Company Has Filed its Quarterly Report on Form 10-Q for Q3 2014 and Anticipates Filing its Annual Report on Form 10-K for FY2014 on or prior to March 31, 2015 PHOENIX , March 2, 2015 /PRNewswire/ -- American Realty Capital Properties, Inc. ("ARCP" or the "Company") (NASDAQ: ARCP) announced today the completion of its restatement and filing of amendments to its 2013 Annual Report on Form 10-K and first and second quarter 2014 Quarterly Reports on Form 10-Q.
Sign-up for American Realty Capital Properties Restates Financial Reports for FY2013 and First Two Quarters of 2014 investment picks
2015/3/2
http://www.ccnmatthews.com/logos2/Microbix.gif TORONTO, ONTARIO --
Sign-up for Microbix Announces New Product Launches in Field of Molecular Diagnostics investment picks
2015/3/2
PHOENIX , March 2, 2015 /PRNewswire/ -- American Realty Capital Properties, Inc. (NASDAQ: ARCP) ("ARCP" or the "Company") announced today its operating results for the three months ended September 30 , 2014.
Sign-up for American Realty Capital Properties Announces Third Quarter 2014 Operating Results investment picks
2015/3/2
LSB Industries, Inc. (NYSE:LXU) (“LSB or the Company”), a manufacturer of chemical products for the agricultural, mining and industrial markets and a leading manufacturer of commercial and residential climate control products, today announced that the LSB Board’s Strategic Committee (the “Strategic Committee”) and the Board of Directors have unanimously determined that the continued execution of the Company’s existing strategic plan is in the best interests of LSB and its shareholders at this time.
Sign-up for LSB Strategic Committee and Board of Directors Unanimously Determine That Continued Execution of Company’s Existing Strategic Plan is in Best Interests of LSB Shareholders at This Time investment picks
2015/3/2
HOUSTON , March 2, 2015 /PRNewswire/ -- EV Energy Partners, L.P. (NASDAQ: EVEP) today announced results for the fourth quarter and full year 2014 and the filing of its Form 10-K with the Securities and Exchange Commission.
Sign-up for EV Energy Partners Announces Fourth Quarter and Full Year 2014 Results, Year-end Proved Reserves, and Amendment to Senior Secured Credit Facility investment picks
2015/3/2
By Dana Mattioli and Gillian Tan Cash-and-stock deal values Freescale at $11.8 billion NXP Semiconductors NV and Freescale Semiconductor Ltd.
Sign-up for NXP, Freescale agree to merge investment picks
2015/3/2
The Bershire Hathaway board has a "very precise" succession plan in place to replace me later today if I "pass out on this show or something else happens," chairman Warren Buffett said in comments on CNBC Monday.
Sign-up for Warren Buffett: There is No 'Jockeying' Between Jain, Abel -CNBC investment picks
2015/3/2
LONDON--Unilever PLC (ULVR.LN) said Monday it is buying REN Skincare for an undisclosed sum.
Sign-up for Unilever Buys REN Skincare for Undisclosed Sum investment picks
2015/3/2
SOUTH SAN FRANCISCO, Calif., March 2, 2015 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA) today announced that its collaborative partner, Memorial Sloan Kettering Cancer Center (MSK) has received breakthrough therapy designation from the U.S. Food and Drug Administration (FDA) for Atara's optioned cytotoxic T lymphocytes activated against Epstein-Barr Virus (EBV-CTL) in the treatment of patients with rituximab-refractory, EBV-associated lymphoproliferative disease (EBV-LPD), a type of malignancy occurring after allogeneic hematopoietic cell transplantation (HCT). Allogeneic HCT is also commonly called a bone marrow transplant.
Sign-up for FDA Grants Breakthrough Therapy Designation to Epstein-Barr Virus (EBV) Targeted T-Cells for Treatment of EBV-Associated Lymphoproliferative Disease investment picks
2015/3/2
Company Announces Termination of Vertex Leases in Cambridgeport, Including Termination Fee of $14 Million SAN DIEGO , March 2, 2015 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced it has recaptured approximately 313,000 square feet of space in the most dynamic and valuable life science real estate market in the world through the termination of Vertex Pharmaceuticals' leases on three properties in Cambridge, Massachusetts effective February 28, 2015 .
Sign-up for BioMed Realty Gets Back 313,000 Square Feet Of Valuable Real Estate In Cambridge Innovation District investment picks
2015/3/2
Alexion Pharmaceuticals, Inc. (Nasdaq:ALXN) announced today that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the Company’s Biologics License Application (BLA) for asfotase alfa, an investigational, first-in-class enzyme replacement therapy for treatment of patients with infantile- and juvenile-onset hypophosphatasia (HPP). The BLA submission is supported by data from 71 treated patients with HPP enrolled in three prospective studies and their extensions, as well as two retrospective natural history studies.
Sign-up for FDA Grants Priority Review for Asfotase Alfa as a Treatment for Patients with Hypophosphatasia investment picks
2015/3/2
LEXINGTON, Mass., March 2, 2015 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc .
Sign-up for T2 Biosystems to Present at the Cowen Healthcare Conference investment picks
2015/3/2
LSB Industries, Inc. (“LSB”) (NYSE:LXU) today announced results for the fourth quarter and full year ended December 31, 2014.
Sign-up for LSB Industries, Inc. Reports Results for the 2014 Fourth Quarter investment picks
2015/3/2
PCTEL, Inc. (NASDAQ:PCTI), a leader in P erformance C ritical Tel ecom solutions, announced today that it had acquired the assets of Nexgen Wireless, Inc., a Schaumburg, Illinois-based company providing Meridian™, a network analysis tool portfolio, and engineering services.
Sign-up for PCTEL Acquires Nexgen Wireless investment picks
2015/3/2
Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) today announced the receipt of a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) following a review of its supplemental New Drug Application (sNDA) for the use of EXPAREL ® (bupivacaine liposome injectable suspension) in nerve block to provide postsurgical analgesia.
Sign-up for Pacira Receives Complete Response Letter from FDA for sNDA Seeking Approval of EXPAREL® Use in Nerve Block to Provide Postsurgical Analgesia investment picks
2015/3/2
Oncolytics Biotech® Inc. Announces Receipt of Orphan Drug Designation from the U.S. FDA for Cancer of the Fallopian Tube Canada NewsWire CALGARY , March 2, 2015 /CNW/ - Oncolytics Biotech ® Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY), a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for its lead product candidate, REOLYSIN ® , for the treatment of cancer of the fallopian tube.
Sign-up for Oncolytics Biotech® Inc. Announces Receipt of Orphan Drug Designation from the U.S. FDA for Cancer of the Fallopian Tube investment picks
2015/3/2
CALGARY , March 2, 2015 /PRNewswire/ - Oncolytics Biotech ® Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY), a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for its lead product candidate, REOLYSIN ® , for the treatment of cancer of the fallopian tube.
Sign-up for Oncolytics Biotech® Inc. Announces Receipt of Orphan Drug Designation from the U.S. FDA for Cancer of the Fallopian Tube investment picks
2015/3/2
Arctic Cat Inc. (Nasdaq:ACAT) today announced that it has completed the acquisition of Motorfist, LLC, a privately owned company based in Idaho Falls, Idaho, that designs, develops and distributes high-performance technical riding gear.
Sign-up for Arctic Cat Acquires Motorfist investment picks
2015/3/2
http://www.marketwire.com/library/MwGo/2015/2/19/11G033624/GI_logo_SINGLE_COLOR-1173897809046.jpg LOUISVILLE, CO--(Marketwired - March 02, 2015) - GlobeImmune, Inc. , (NASDAQ: GBIM) today announced that Timothy C.
Sign-up for GlobeImmune to Present at the 27th Annual ROTH Conference investment picks
2015/3/2
CAMBRIDGE, Mass.
Sign-up for Akamai Acquires Xerocole investment picks
2015/3/2
—Transaction Will Create a $19.8 Billion Asset Commercial Bank— LOS ANGELES and DURHAM, N.C., March 2, 2015 (GLOBE NEWSWIRE) -- PacWest Bancorp (Nasdaq:PACW) ("PacWest") and Square 1 Financial, Inc. (Nasdaq:SQBK) ("Square 1") today announced the signing of a definitive agreement and plan of merger (the "Agreement") whereby PacWest will acquire Square 1 in a transaction valued at approximately $849 million.
Sign-up for PacWest Bancorp and Square 1 Financial, Inc. Agree to Merge investment picks
2015/3/2
Leading U.S. toymaker JAKKS Pacific, Inc. (Nasdaq: JAKK) announced today that it has secured a licensing agreement with LAFIG and Sony Pictures Consumer Products to produce toys and related products based on the Smurfs franchise including the classic Smurfs brand and the upcoming Smurfs feature film premiering in August 2016.
Sign-up for JAKKS Pacific Secures Worldwide, Master Toy Agreement for the Smurfs Franchise investment picks
2015/3/2
TSO3 Announces full exercise of underwriters' option to purchase additional units Canada NewsWire Ticker: TSX – TOS Shares Outstanding: 73,399,656 Not for distribution to U.S. news wire services or dissemination in the United States .
Sign-up for TSO3 Announces full exercise of underwriters' option to purchase additional units investment picks
2015/3/2
By Rogerio Jelmayer SAO PAULO--Brazilian homebuilder Gafisa SA saw its net profit tumble 99% in the fourth quarter, reflecting the absence of a one-time gain and the impact of Brazil's sluggish economy.
Sign-up for Brazil's Gafisa 4Q Net Profit Drops 99% investment picks
2015/3/2
By Jason Ng KUALA LUMPUR, Malaysia--CIMB Group Holdings Bhd.
Sign-up for CIMB Group Appoints New Chief Financial Officer investment picks
2015/3/2
Company provides resources for high risk populations - those with diabetes, high blood pressure and minority populations DENVER , March 2, 2015 /PRNewswire/ -- DaVita Kidney Care , a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, is encouraging people to take a 60-second quiz to learn about their risk for chronic kidney disease during March, National Kidney Month.
Sign-up for DaVita Encourages People to Get to Know Their Kidneys During National Kidney Month investment picks
2015/3/2
By Sara Sjolin, MarketWatch Berkshire Hathaway slips after earnings LONDON (MarketWatch) -- U.S. stocks were set to kick off March on an upbeat note on Monday, with futures edging higher ahead of raft of economic data -- including consumer spending and manufacturing numbers -- that will provide a health check on the economy.
Sign-up for MARKET SNAPSHOT: U.S. Stocks: Futures Climb Ahead Of Data Deluge investment picks
2015/3/2
MCLEAN, Va.
Sign-up for CYREN to Present at ROTH Conference investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: 500.com Limited Provides Additional Information on Temporary Suspension of Sales by Provincial Sports Lottery Administration Centers to CYREN to Present at ROTH Conference
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent